I

Invasight AG

3 employees

Invasight is a clinical biotech company that focused on revolutionizing cell invasion research.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
therapeutics
Health Care
pharam
protein-protein
protein to
Biopharma
oncology
biotech

Date founded

2019

Funding rounds raised

Total raised

$4.6M

from 8 investors over 8 rounds

I

Invasight AG raised $4.6M on June 7, 2022

Investors: AVANTECA Partners, Wille Finance, OCCIDENT, Zürcher Kantonalbank and High-Tech Gründerfonds

I

Invasight AG raised undisclosed on November 16, 2020

Investors: Business Angels Switzerland

I

Invasight AG raised $40K on June 6, 2019

Investors: Venture Kick

I

Invasight AG raised $10K on February 19, 2019

Investors: Venture Kick

FAQ